Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 34

1.

APOC1 T45S polymorphism is associated with reduced obesity indices and lower plasma concentrations of leptin and apolipoprotein C-I in aboriginal Canadians.

Lahiry P, Cao H, Ban MR, Pollex RL, Mamakeesick M, Zinman B, Harris SB, Hanley AJ, Huff MW, Connelly PW, Hegele RA.

J Lipid Res. 2010 Apr;51(4):843-8. doi: 10.1194/jlr.P002014. Epub 2009 Oct 6.

2.

Hypertriglyceridemia: phenomics and genomics.

Hegele RA, Pollex RL.

Mol Cell Biochem. 2009 Jun;326(1-2):35-43. doi: 10.1007/s11010-008-0005-1. Epub 2009 Jan 7.

PMID:
19130180
3.

APOA5 genetic variants are markers for classic hyperlipoproteinemia phenotypes and hypertriglyceridemia.

Wang J, Ban MR, Kennedy BA, Anand S, Yusuf S, Huff MW, Pollex RL, Hegele RA.

Nat Clin Pract Cardiovasc Med. 2008 Nov;5(11):730-7. doi: 10.1038/ncpcardio1326. Epub 2008 Sep 9.

PMID:
18779834
4.

Abetalipoproteinemia: two case reports and literature review.

Zamel R, Khan R, Pollex RL, Hegele RA.

Orphanet J Rare Dis. 2008 Jul 8;3:19. doi: 10.1186/1750-1172-3-19. Review.

5.

Polygenic determinants of severe hypertriglyceridemia.

Wang J, Ban MR, Zou GY, Cao H, Lin T, Kennedy BA, Anand S, Yusuf S, Huff MW, Pollex RL, Hegele RA.

Hum Mol Genet. 2008 Sep 15;17(18):2894-9. doi: 10.1093/hmg/ddn188. Epub 2008 Jul 1.

6.

Emerging antidyslipidemic drugs.

Pollex RL, Joy TR, Hegele RA.

Expert Opin Emerg Drugs. 2008 Jun;13(2):363-81. doi: 10.1517/14728214.13.2.363 . Review.

PMID:
18537526
7.

Genetics of metabolic syndrome.

Joy T, Lahiry P, Pollex RL, Hegele RA.

Curr Diab Rep. 2008 Apr;8(2):141-8. Review.

PMID:
18445357
8.

Association between the FTO rs9939609 polymorphism and the metabolic syndrome in a non-Caucasian multi-ethnic sample.

Al-Attar SA, Pollex RL, Ban MR, Young TK, Bjerregaard P, Anand SS, Yusuf S, Zinman B, Harris SB, Hanley AJ, Connelly PW, Huff MW, Hegele RA.

Cardiovasc Diabetol. 2008 Mar 13;7:5. doi: 10.1186/1475-2840-7-5.

9.

Common variants APOC3, APOA5, APOE and PON1 are associated with variation in plasma lipoprotein traits in Greenlanders.

Lahiry P, Ban MR, Pollex RL, Feldman RD, Sawyez CG, Huff MW, Young TK, Bjerregaard P, Hegele RA.

Int J Circumpolar Health. 2007 Dec;66(5):390-400.

10.

Uncloaking the genetic determinants of metabolic syndrome.

Lahiry P, Pollex RL, Hegele RA.

J Nutrigenet Nutrigenomics. 2008;1(3):118-25. doi: 10.1159/000112459. Epub 2008 Feb 20. Review.

PMID:
19776621
11.

Association between the -455T>C promoter polymorphism of the APOC3 gene and the metabolic syndrome in a multi-ethnic sample.

Pollex RL, Ban MR, Young TK, Bjerregaard P, Anand SS, Yusuf S, Zinman B, Harris SB, Hanley AJ, Connelly PW, Huff MW, Hegele RA.

BMC Med Genet. 2007 Dec 20;8:80.

12.

Genetic determinants of plasma lipoproteins.

Pollex RL, Hegele RA.

Nat Clin Pract Cardiovasc Med. 2007 Nov;4(11):600-9. Review.

PMID:
17957207
13.

Resequencing genomic DNA of patients with severe hypertriglyceridemia (MIM 144650).

Wang J, Cao H, Ban MR, Kennedy BA, Zhu S, Anand S, Yusuf S, Pollex RL, Hegele RA.

Arterioscler Thromb Vasc Biol. 2007 Nov;27(11):2450-5. Epub 2007 Aug 23.

14.

Copy number variation in the human genome and its implications for cardiovascular disease.

Pollex RL, Hegele RA.

Circulation. 2007 Jun 19;115(24):3130-8. Review. No abstract available.

15.

Apolipoprotein A-V genetic variation and plasma lipoprotein response to fibrates.

Hegele RA, Pollex RL.

Arterioscler Thromb Vasc Biol. 2007 Jun;27(6):1224-7. No abstract available.

16.

Peroxisome proliferator-activated receptor gamma polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes.

Pollex RL, Mamakeesick M, Zinman B, Harris SB, Hegele RA, Hanley AJ.

J Diabetes Complications. 2007 May-Jun;21(3):166-71.

PMID:
17493550
17.

Genetic determinants of statin intolerance.

Oh J, Ban MR, Miskie BA, Pollex RL, Hegele RA.

Lipids Health Dis. 2007 Mar 21;6:7.

18.

Genomic copy number variation and its potential role in lipoprotein and metabolic phenotypes.

Pollex RL, Hegele RA.

Curr Opin Lipidol. 2007 Apr;18(2):174-80. Review.

PMID:
17353666
19.

Quantitative and qualitative differences in subcutaneous adipose tissue stores across lipodystrophy types shown by magnetic resonance imaging.

Al-Attar SA, Pollex RL, Robinson JF, Miskie BA, Walcarius R, Little CH, Rutt BK, Hegele RA.

BMC Med Imaging. 2007 Mar 12;7:3.

20.

NPC1L1: evolution from pharmacological target to physiological sterol transporter.

Huff MW, Pollex RL, Hegele RA.

Arterioscler Thromb Vasc Biol. 2006 Nov;26(11):2433-8. Epub 2006 Sep 14. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk